- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 192 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 146 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- January 2025
- 180 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- June 2025
- 276 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- August 2024
- 110 Pages
Asia Pacific
From €4434EUR$4,950USD£3,779GBP
- Report
- May 2025
- 200 Pages
Europe
From €2230EUR$2,490USD£1,901GBP
- Report
- September 2024
- 200 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 77 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- November 2024
- 183 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- July 2024
- 157 Pages
Global
From €3807EUR$4,250USD£3,245GBP
- Report
- January 2025
- 429 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- May 2025
- 196 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 187 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP

The Defibrillator market is a segment of the Cardiovascular Devices industry. Defibrillators are medical devices used to restore normal heart rhythm in patients suffering from cardiac arrhythmias. These devices are used in both in-hospital and out-of-hospital settings, and are typically used in emergency situations. Defibrillators can be divided into two main categories: implantable and external. Implantable defibrillators are surgically implanted into the patient's chest, while external defibrillators are used externally and are typically used in emergency situations.
Defibrillators are used to treat a variety of cardiac conditions, including ventricular fibrillation, ventricular tachycardia, and atrial fibrillation. The market for defibrillators is expected to grow due to the increasing prevalence of cardiovascular diseases, technological advancements, and the increasing demand for home-based defibrillators.
Some of the major companies in the Defibrillator market include Medtronic, St. Jude Medical, Biotronik, Boston Scientific, and Philips Healthcare. Show Less Read more